Conformis Continues Slide Due to Aetna Coverage Denials

Conformis reported 3Q19 revenue of USD $17.3 million, -40.3% vs. 3Q18.

The drastic reduction to growth in knees is primarily due to the one-time $10.5 million royalty settlement received from Smith+Nephew in 3Q18; however, product revenue for the quarter was down -6.7% due to Aetna coverage denials
While Aetna has not yet revised...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us